Dr. Auriel Willette and his team of researchers are continuing their take a look at how obesity-related issues are related to metabolic process diabetes.
The link between their latest research, published from the Journal of Alzheimer’s, specify a fresh biomarker, insulin-like growth factor binding protein 2 (IGFBP-2), and how this could lead to ones likelihood to create Alzheimer’s disease. IGFBP-2 allows you to regulate energy metabolism by affecting blood sugar levels.
See the whole story because of the Department of Food Science and Human Nutrition.
